New Stem Cell Therapy Trial Offers Hope for Millions Living with Untreatable Advanced Dry Macular Degeneration

The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
Science Daily

Stem cell therapy helps AMD patients see again

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
News-Medical.Net

Inflammation control can protect against AMD-like retinal damage

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

Reducing inflammation may protect against early age-related macular degeneration-like vision loss

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

Stunning Results: Revolutionary Retinal Chip Lets Patients With Severe Vision Loss Read Again

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...

EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Relate…

No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety ...

Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape | DelveInsight

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...